180 Life financial statements provide useful quarterly and yearly information to potential 180 Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on 180 Life financial statements helps investors assess 180 Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting 180 Life's valuation are summarized below:
Market Capitalization
3.4 M
Earnings Share
7.98
There are over one hundred nineteen available fundamental measures for 180 Life, which can be analyzed over time and compared to other ratios. Active traders should verify all of 180 Life latest fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself this quarter and beyond.
180 Life stakeholders use historical fundamental indicators, such as 180 Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although 180 Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in 180 Life's assets and liabilities are reflected in the revenues and expenses on 180 Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 180 Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
7.98
Return On Assets
(0.52)
Return On Equity
(1.74)
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.